We work with clients to ensure an appropriate balance between the technical attributes & clinical unmet needs associated with drugs in development and relevant commercial factors affecting their potential value for each phase of development.

Atebion BDS offers Business Development Services, Business Decision Support and Brand Development Strategies. We focus on supporting companies in their assessments, commercial evaluations & negotiations for in-license opportunities, as well as in shaping packages for out-licensing.

Robust therapeutic knowledge, combined with clear, early insight of key techno-commercial issues and sound clinical development experience drives more effective and efficient pathways to deal completion and product commercialization. Whether you are in clinical development, launching a product or are managing a portfolio across the development and product life-cycle, this expertise enables you to optimise probability of success and minimize risk. High-quality techno-commercial evaluations can help to ensure;

• Regulatory requirements are being met in each jurisdiction
  for study execution and commercialization.
• Data is scientifically meaningful to the clinical, regulatory, payer and patient communities.
• Appropriate clinical trials are conducted in the most relevant markets and regions, allowing optimal launch times in areas of highest commercial potential and clinical need.
• Product positioning and key claims are relevant to each major market and each stakeholder.
• Strategic planning is completed utilising appropriate levels of insight from around the globe, ensuring your clinical development plan is built for commercial success from the very first in-patient trials.
• Licensing packages are more commercially robust with demonstrable proof of sound market awareness, including an understanding of the evolving payer landscape across regions and the changing regulatory requirements.
• Higher probability of deal making success to support your strategic and financial goals
• High quality techno-commercial assessments opf opportunities underpin many investment decisions and represent a core component of our services
• We assist Multi-Nationals, Biotechs, Early-stage discovery groups, Start-ups and Investors in evaluating opportunities, portfolios and deal strategies
• We provide Company valuations for Start-up or early phase Companies ahead of Investment Rounds